The Caravan Health Accountable Care Symposium brings together community hospital leaders, experts from government and industry, clinical staff, and others to share their visions, strategies, and experiences in executing value-based payment models.
ACO, Webinars & Events, Value-Based Care, Population Health
Caravan Health Average Scores is 93.2 points vs Standard Medicare Average of 65.7
Policy, Blogs & News, Quality
Providers must realign clinical workflows as well as revenue models, and physician leaders must convince their peers that these changes will pay off in the long run.
ACO, Webinars & Events, Value-Based Care, Population Health, Caravan Culture
In just over a year as Chief Medical Officer for Caravan Health, Dr. Anna Loengard has brought a clear focus to how our partners use clinical data in accountable care. Working closely with our ACO medical directors and clinical staff, she has guided our ACOs through clinical care transformation. She will bring us up to date on this work next month at our third annual Accountable Care Symposium in Phoenix, AZ.
Webinars & Events, Caravan Culture
We will have industry experts at the head of all of our major operating areas, positioning Caravan Health for continued growth and success in the future.
Blogs & News, Caravan Culture
On Thursday, November 1, CMS released the 2019 Medicare Physician Fee Schedule and Quality Payment Program final rule, including important updates to the Merit-Based Incentive Payment System (MIPS).
ACO, Policy, Blogs & News, Value-Based Care
Veteran Washington, DC Analyst Rodney Whitlock Will Join the Symposium to Discuss Health Care After the 2018 Elections
ACO, Blogs & News, Caravan Culture
Rather than providing care in a reactive way, by addressing the issue that comes up when a patient comes into a practice or visits an emergency room, Caravan Health is pushing for a more proactive model.
ACO, Policy, Blogs & News, Value-Based Care, Rural
Prescription drugs are a large and growing segment of Medicare spending. In addition to the more than $90 billion spent each year for the pharmacy drug benefit of Medicare part D, MedPAC reports that the government and beneficiaries spent about $29 billion for drugs and biologics under part B in 2016.
ACO, Policy, Blogs & News, Value-Based Care